OFFICIAL PUBLICATION OF

by its subsidiary APPco

High demand puts pressure on Shingrix supply chain

Nicholas O’Donoghue 02/02/2024

GSK expects to deliver 1.1 million doses of its shingles vaccine to the Commonwealth in the first half of 2024 Higher than anticipated demand for the National Immunisation Program (NIP) listed Shingrix vaccine is impacting the supply of the jab to pharmacies. Since the launch of the NIP Vaccination in Pharmacy (NIPVIP) program on 1

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

No products available

60DD doesn’t help with the shortage like Duodart

Paul Lai

Doctor of Pharmacy addresses anomaly

I thought it was from 1 Jan, not 1 July.

taron p

Doctor of Pharmacy addresses anomaly

The accreditation and the title "Dr" is the norm set for all academic disciplines for Extended Master Program and should…

Benjamyn Sung

No products available

Anyone doubting the impact this has on a community pharmacists workload over the course of a week needs to spend…

Jeremy McLernon

High demand puts pressure on Shingrix supply chain

Previous Pharmacies claim over $227k through NIPVIP in January

Next John Coppock Pharmacist Wellbeing Award launched

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous Pharmacies claim over $227k through NIPVIP in January

Next John Coppock Pharmacist Wellbeing Award launched

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.